Varenicline
CHANTIX, Tyrvaya, Varenicline
Partial Cholinergic Nicotinic Agonist
NADAC/unit
$0.3730
No Shortage
Tier 1: 80.9%
PA Req: 0.3%
20 Manufacturers
40 ANDAs
indicated for use as an aid to smoking cessation treatment.
vs. brand CHANTIX: Generic saves up to 96% per unit
Market Intelligence
2025-12-17 Class III Recall: Dr. Reddy's Laboratories, Inc.
Generic Manufacturers
AJANTA PHARMA LTDALKEM LABORATORIES LTDAPOTEX INCAUROBINDO PHARMA LTDDR REDDYS LABORATORIES LTDHETERO LABS LTD UNIT IIIKANCHAN HEALTHCARE INCLUPIN LTDMACLEODS PHARMACEUTICALS LTDMANKIND PHARMA LTDMICRO LABS LTDNE RX PHARMA LLCOYSTER POINT PHARMA INCPF PRISM CVPH HEALTH LTDPHARMOBEDIENT CONSULTING LLCPIRAMAL HEALTHCARE UK LTDREGCON HOLDINGS LLCSHILPA MEDICARE LTDUMEDICA LABORATORIES PRIVATE LTDVIWIT PHARMACEUTICAL CO LTDZYDUS WORLDWIDE DMCC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.